Starpharma Holdings Limited
SPHRF
$0.084
$0.00020.24%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.76M | -1.81M | -2.35M | -2.34M | -336.90K |
| Total Depreciation and Amortization | 175.60K | 180.60K | 179.90K | 179.50K | 185.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 930.90K | 957.20K | -359.10K | -358.40K | 835.20K |
| Change in Net Operating Assets | -- | -- | -461.30K | -460.30K | -- |
| Cash from Operations | -650.30K | -668.70K | -2.99M | -2.98M | 683.60K |
| Capital Expenditure | -10.10K | -10.40K | -26.40K | -26.30K | -2.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -10.10K | -10.40K | -26.40K | -26.30K | -2.90K |
| Total Debt Issued | -- | -- | 443.00K | 443.00K | -- |
| Total Debt Repaid | -525.00K | -525.00K | -245.00K | -245.00K | -2.57M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -342.10K | -351.80K | 130.50K | 130.20K | -1.68M |
| Foreign Exchange rate Adjustments | -2.00K | -2.00K | -4.00K | -3.90K | 1.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.00M | -1.03M | -2.89M | -2.88M | -993.50K |